About this resource

About

Bright Basin 45 / Sable Juncture helps people assess ibogaine-related mental-health claims through clear summaries of evidence, risks, and regulatory context. We aim to separate preliminary findings from established care and to make uncertainty explicit.

For practical referrals or clinical decisions consult qualified professionals. Bright Basin 45 is an independent information resource, not a clinic or medical provider.

Explore services and guidance
Close-up photographic detail related to ibogaine evidence and editorial review

Our editorial approach

We assemble and assess evidence from clinical registries, peer-reviewed literature, regulatory statements, and publicly available safety reports, then summarise findings in plain language. Where appropriate we contextualize claims using authoritative sources such as the National Institutes of Health; for example, readers will find citations to primary databases and overview pages when we discuss methodological standards (National Institutes of Health). We also consult standard biomedical reference points like the National Library of Medicine to verify terminology (NCBI / PubMed).

How we vet sources

We prioritise peer-reviewed work, registered clinical trials, and official guidance from regulatory agencies; we treat anecdotal reports as hypothesis-generating rather than confirmatory. Our summaries highlight limitations — sample sizes, study design, conflicts of interest, and reproducibility — so readers can judge strength of evidence themselves.

What we do not do

We do not offer medical advice, clinical care, or referrals to treatment providers. Readers seeking treatment should consult licensed clinicians and local health authorities for personalised care.

Editorial principles

Our work is guided by concise principles that shape what we publish and how.

  • Independence
    We do not offer clinical services and maintain editorial independence from treatment providers.
  • Evidence before hype
    Claims are assessed against the best available studies and registry data.
  • Safety clarity
    We present risks, screening considerations, and known harms transparently.
  • Plain language
    Technical findings are summarized for non-specialist readers without oversimplifying.

Who this is for

Our audience includes patients, families, clinicians, researchers, and policy-minded adults evaluating ibogaine claims. We aim to provide a reliable entry point that links to original studies and official registries.

Return to overview

When we mention treatment programs or clinical sites in context, we reference publicly visible directories and informational hubs to help readers verify sources. For example, regional treatment summaries and provider directories can be found on sites such as ibogaine treatment centers europe and community-focused resources like ibogaine Bwiti resources. Our pages also compare withdrawal- and benefit-focused reporting against registry-style compilations such as ibogaine withdrawal reports and discussion pages like ibogaine benefits.

Independent by design

Bright Basin 45 is intentionally independent: we do not operate as a clinic, treatment provider, or licensed medical authority. Content is informational and should not replace clinical judgement or legal advice.

How is information updated?

We review literature on a rolling basis and update summaries when significant new studies, regulatory actions, or safety data appear. We prioritise primary sources and registry records, and we flag items where consensus is lacking.

How can I use these pages?

Use Bright Basin 45 to orient yourself to the state of evidence and to find original sources. If you are seeking care, consult licensed clinicians and local health services; our services page describes the kinds of non-clinical support we provide to help people interpret evidence.